Replies to post #152948 on Amarin Corp Plc (AMRN)

[MateoPaisa]

I've made well over $100k. Never earned anything like it from one ticker symbol in my life. Im positioned to hit a million without an obscene increase in share price.

Life is good and looking even better

[Nukemtiltheyglow]

Dang it JL, I still watch cartoons. As a matter of fact I was watching Foghorn Leghorn while typing my last post......"I say, I say....boy" let me show you how it's done. Too bad they don't make cartoons like that anymore.

I've known for a few years Louiebolouie was.....help me out..... A "Girl", a female, a woman, what is the right terminology? Not that I'm stereotypical here, but you don't see the fairer sex investing in high risk investments, so, Louie kind of broke my paradigm about female investors. Hopefully, this paradigm will change. Or should males go the opposite direction, be more conservative?

Foghorn Nuke

[Nukemtiltheyglow]

Hey, what about Howdy Doody, Captain Kangaroo, Mr Green jeans, and who was the lady with the sock puppets?

You definitely should enjoy your new ride JL, one of life's little pleasures is to drive an awesome ride with the top down, except of course when it's raining.

Just isn't for me I guess, I'm thinking about a winery.

[maverick_1]

As I indicated to Marzan I'm up a few hundred K. Unlike Marzan I'm unleveraged: NO Call Options.
Wasn't my only issue to having scored over 100K in one issue. And one of those was a brazen call
a SHORT that I made a name for myself amongst a core of high performance hedge funds when I
was in my 30's. The short close to doubled and generated a big call for funds. The reason it almost
doubled: the partner in charge of research at Morgan Stanley was the drug analyst who wore another
hat: IBK trying to raise funds for LVAD 20 yrs ahead of approval.; that company had another operation
and competed against Goretex started up by DuPont ex patriates. Put up the dough! Stuck to my convictions.
Shockingly after a CEO interview was asked what I had in my portfolio! He had a large short position in
the same issue: a million chance in one- never had any corporate official ask that! We compared and traded notes.Covered 1/4 at cost basis of $6.50. The rest covered close to bankruptcy at 25 cents.

Looking for similar like results as AMRN short term from an investment in NWBO whether thru top line GBM data and/or partnership.

Thanks JL for your creative clinical trial on Vascepa!

DIFFERENT STROKES FOR DIFFERENT STROKES